TP53 and non-small cell lung carcinoma: Additionally, we activated p53 with different p53-inducing agents, including Nutlin-3, 5-FU, cisplatin, and etoposide in various NSCLC cells, and found that the expression of DCP1B was upregulated in p53-wide type NSCLC cells (A549, H460, H1395) (Fig. 1I–N) but not in p53-deficiency NSCLC cells (H1299, Calu-1) (Fig. S1F–I) and p53-mutation NSCLC cells (H1975, PC9) (Fig. S1J–Q).